Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

BioScience Nottingham

Nottingham receives go ahead for new £30m life science facility

August 19, 2015 Manufacturing and Production, Research and Development BioCity Nottingham, R&D

Hundreds of pharma jobs are expected to be created in Nottingham after the construction of a new £30 million life …
News

Confronting the ‘danger’ of blocking progress on clinical trial transparency

August 19, 2015 Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

The Ethical Medicines Industry Group and Sense About Science – a co-founder of the ALLTrials campaign – have written a …
Feature

HRA must continue ‘progress towards clinical trial transparency’

August 19, 2015 Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

Campaigners and industry leaders have urged the Health Research Authority to ensure that its work to bring about full transparency …
News
car_t-cells

Kite Pharma says trial death was unrelated to KTE-C19

August 18, 2015 Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma

Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …
News
ALS research

Biogen collaborates with ALSA and Columbia University on genomic-based ALS treatments

August 18, 2015 Research and Development

Biogen, the ALS Association and Columbia University Medical Center (CUMC) have announced a new collaboration aimed at better understanding the differences …
News
Chest x ray

Roche lung cancer therapy succeeds in mid-stage trial

August 17, 2015 Research and Development, Sales and Marketing Genentech, Roche, atezolizumab, lung cancer, non-small cell lung cancer

Roche’s biotech arm Genentech has scored positive results in a pivotal Phase II study of its investigational cancer immunotherapy atezolizumab. …
News
Keytruda image

Merck in immuno-oncology collaboration with major cancer research centre

August 14, 2015 Research and Development Cancer, Merck, keytruda, oncology

Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …
News

Abbvie and Roche report success in Phase II leukaemia trial

August 13, 2015 Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax

AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …
News
contrave

Orexigen and Takeda reboot Contrave collaboration

August 12, 2015 Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs

Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …
News
Novavax

Novavax rides high on crest of RSV vaccine wave

August 12, 2015 Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines

The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …
News
MedImmune building

MedImmune and Inovio collaborate on cancer vaccine

August 11, 2015 Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology

MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …
News
aprecias_zipdose_technology_in_action

Aprecia boosts 3D printing facilities at new US site

August 11, 2015 Manufacturing and Production, Research and Development

Aprecia Pharmaceuticals, which scored a world-first by becoming the first manufacturer to gain FDA approval for a three-dimensional printed (3DP) …
News
George Freeman

UK medical innovation backed with £18m Biomedical Catalyst fund

August 10, 2015 Research and Development, Sales and Marketing

Life Sciences Minister George Freeman has announced an £18 million fund for the next generation of UK medical advances. Twelve …
News
R&D

Sanofi, Evotec and Apeiron partner on immuno-oncology

August 10, 2015 Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours

Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …
News
MedImmune building Cambridge

MedImmune and Mirati to partner on lung cancer combo

August 6, 2015 Research and Development AstraZeneca, Cancer, MedImmune, Mirati, Mirati Therapeutics, NSCLC, durvalumab, immuno-oncology, immunotherapy, lung cancer, mocetinostat

MedImmune is entering into an exclusive clinical trial collaboration with US-based Mirati Therapeutics to test a novel immuno-oncology combination in …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026